Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q96SZ6
UPID:
CK5P1_HUMAN
Alternative names:
CDK5 activator-binding protein C42; CDK5 regulatory subunit-associated protein 1; mt-tRNA-2-methylthio-N6-dimethylallyladenosine synthase; mt-tRNA-N6-(dimethylallyl)adenosine(37) methylthiotransferase
Alternative UPACC:
Q96SZ6; A8K7R0; Q5QP46; Q5QP47; Q5QP48; Q675N4; Q675N5; Q9BVG6; Q9BWZ5; Q9H859; Q9NZZ9; Q9Y3F0
Background:
Mitochondrial tRNA methylthiotransferase CDK5RAP1, also known as CDK5 activator-binding protein C42, plays a pivotal role in mitochondrial protein synthesis. It catalyzes the conversion of N6-(dimethylallyl)adenosine to 2-methylthio-N6-(dimethylallyl)adenosine at position 37 of mitochondrial DNA-encoded tRNAs. This enzymatic activity is crucial for accurate protein translation and respiratory chain efficiency, highlighting its importance in mitochondrial function.
Therapeutic significance:
Understanding the role of Mitochondrial tRNA methylthiotransferase CDK5RAP1 could open doors to potential therapeutic strategies.